Acclaro Medical has achieved Health Canada approval for its UltraClear® 2910 nm fiber laser system. This milestone introduces a novel approach to skin rejuvenation treatments in the Canadian market.

Acclaro Medical’s UltraClear® 2910 nm fiber laser system distinguishes itself through proprietary MID IR fiber laser technology and 3DIntelliPulse™ capabilities that enable both superficial resurfacing with 3DMIRACL® and deeper tissue remodeling with Laser Coring™. The brand claims its device achieves these benefits with reduced thermal damage compared to conventional lasers. The fiber laser system’s cold ablative properties aim to minimize patient discomfort while addressing diverse skin concerns — from fine lines to more pronounced signs of aging.

Acclaro Medical has partnered with Xcite Technology, a prominent distributor of aesthetic devices, to facilitate nationwide adoption by Canadian clinics.

Image Credit: Acclaro Medical